These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19078991)

  • 1. The B-cell calcium sensor predicts progression of chronic lymphocytic leukemia.
    Hammond CM; Shi Y; White D; Cervi D; Tomic J; Spaner DE
    Leukemia; 2009 Feb; 23(2):426-9. PubMed ID: 19078991
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic lymphocytic leukemia (CLL): a model for understanding and treating chronic B-cell malignancies.
    Caligaris-Cappio F
    Rinsho Ketsueki; 2013 Oct; 54(10):1838-42. PubMed ID: 24064834
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional expression of the calcitonin receptor by human T and B cells.
    Cafforio P; De Matteo M; Brunetti AE; Dammacco F; Silvestris F
    Hum Immunol; 2009 Sep; 70(9):678-85. PubMed ID: 19445988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia.
    De Fanis U; Dalla Mora L; Romano C; Sellitto A; Tirelli A; Lucivero G
    Haematologica; 2002 Mar; 87(3):325-7. PubMed ID: 11869948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the B-cell receptor in chronic lymphocytic leukemia: where do we stand?
    Fais F; Bruno S; Ghiotto F
    Ital J Anat Embryol; 2010; 115(1-2):79-84. PubMed ID: 21072994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heterogeneity of the cases of chronic B-cell leukemia and the heterogeneity of leukemic cell populations].
    Kowal M; Rupniewska ZM
    Acta Haematol Pol; 1990; 21(1):32-45. PubMed ID: 2260408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
    Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
    Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant CD8 expression in B-chronic lymphocytic leukemia: report of five cases.
    Parisi-Duchêne E; Mazurier I; Moskovtchenko P
    Acta Haematol; 2006; 115(1-2):74-7. PubMed ID: 16424654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [B-lymphocytes in the pleural effusion of chronic lymphocytic leukemia].
    Molina M; Ortega G; Martínez F; Sola J
    Med Clin (Barc); 1995 Oct; 105(12):478. PubMed ID: 7490944
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis.
    Contri A; Brunati AM; Trentin L; Cabrelle A; Miorin M; Cesaro L; Pinna LA; Zambello R; Semenzato G; Donella-Deana A
    J Clin Invest; 2005 Feb; 115(2):369-78. PubMed ID: 15650771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD38+ chronic lymphocytic leukaemia cells co-express high levels of ZAP-70 and are functionally distinct from their CD38- counter-parts.
    Pepper C; Brennan P; Alghazal S; Ward R; Pratt G; Starczynski J; Lin T; Rowntree C; Fegan C
    Leukemia; 2006 Apr; 20(4):743-4. PubMed ID: 16452999
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser microdissection for the assessment of the clonal relationship between chronic lymphocytic leukemia/small lymphocytic lymphoma and proliferating B cells within lymph node pseudofollicles.
    Vandewoestyne ML; Pede VC; Lambein KY; Dhaenens MF; Offner FC; Praet MM; Philippé JJ; Kipps TJ; Deforce DL
    Leukemia; 2011 May; 25(5):883-8. PubMed ID: 21321570
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of T cells on B cell colony formation in patients with B-chronic lymphocytic leukemia].
    Abe S; Ishiyama T; Wakabayashi Y
    Rinsho Ketsueki; 1988 Jul; 29(7):1036-40. PubMed ID: 3263518
    [No Abstract]   [Full Text] [Related]  

  • 17. [Which cells during the process of differentiation give rise to chronic B-cell lymphocytic leukemia? I].
    Rupniewska ZM; Rozynkowa D
    Postepy Hig Med Dosw; 1988; 42(2):198-223. PubMed ID: 3076000
    [No Abstract]   [Full Text] [Related]  

  • 18. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.
    Pangalis GA; Angelopoulou MK; Vassilakopoulos TP; Siakantaris MP; Kittas C
    Semin Hematol; 1999 Apr; 36(2):104-14. PubMed ID: 10319379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia.
    Campàs C; Dalmau M; Montaner B; Barragán M; Bellosillo B; Colomer D; Pons G; Pérez-Tomás R; Gil J
    Leukemia; 2003 Apr; 17(4):746-50. PubMed ID: 12682632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral blood.
    Bhattacharya N; Diener S; Idler IS; Barth TF; Rauen J; Habermann A; Zenz T; Möller P; Döhner H; Stilgenbauer S; Mertens D
    Leukemia; 2011 Apr; 25(4):722-6. PubMed ID: 21242995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.